Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7

doi:10.12047/j.cjap.5601.2017.121

Abstract

Abstract: Objective: To study the effects of knockdown of miR-449a on the proliferation and migration of human breast cancer cell line Michigan Cancer Foundation-7 (MCF-7).Methods: Using miRNA chip screening of the differential expressions of miRNA in human breast cancer cell MCF-7 and normal breast cells MCF-10A. The inhibitor of miR-449a was synthesized by chemical and detected by real-time PCR after transfection aimed to verify the expression. Cell Counting Kit-8 (CCK-8) assay was used to detect the ability of cell proliferation after transfection with miR-449a inhibitor. Scratch assay was used to detect cell migration of MCF-7, and cell invasion ability was showed by transwell assay; The MCF-7 cell proliferation and migration related proteins, β-catenin and E-cadherin, were detected by Western blot. The potential target gene of miR-449a was predicted by bioinformatics software, and Notch homolog 1 (Notch 1) was proved to be the target gene of miR-449a by luciferase assay.Results: MCF-7 and MCF-10a cells were collected separately, and miRNA chip results showed that the level of miR-449a in MCF-7 cells was significantly higher than that of MCF-10A. In this study, the cells were divided into mock group, negative control group (NC group) and treatment group, the MCF-7 cells were collected before and after treatment and CCK-8 results showed that knockdown of miR-449a decreased MCF-7 cell proliferation ability significantly. Scratch assay results showed that downregulated miR-449a was related to the decreased metastasis of MCF-7 cells. Transwell results showed that knockdown of miR-449a inhibited the invasion of MCF-7 cells. Western blot showed the expression of β-catenin was decreased and the expression of E-cadherin was increased after knockdown of miR-449a. Luciferase assay showed that miR-449a could significantly decrease the luciferase activity of Notch homolog 1-untranslated region (Notch 1-3'-UTR) plasmid (P<0.01).Conclusion: Inhibition of miR-449a in breast cancer cell line MCF-7 can significantly inhibit the proliferation and migration of cancer cells, which may be achieved by decreasing the expression of Notch 1 protein.

Key words: miR-449a, human breast cancer cell line MCF-7, proliferation, migration

WANG Hong-lei, XIAO Yi, WU Li, MA Da-chang. Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7[J]. CJAP, 2017, 33(6): 508-513.

References

[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-386.
[2] 王攀, 谢敖文, 范钦桥, 等. miR-139-5p靶向转化生长因子-β1抑制肝癌细胞侵袭转移的机制[J]. 中华肝胆外科杂志, 2016, 22(1):17-23.
[3] Zhao S, Sun H, Jiang W, et al. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition[J]. Mol Cancer, 2017, 16(1):12.
[4] Patel N, Garikapati KR, Ramaiah MJ, et al. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1. Life Sci, 2016, 164:60-70.
[5] You J, Zhang Y, Li Y, et al. MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer[J]. Am J Cancer Res, 2015, 5(9):2730-2744.
[6] Liu S, Liu K, Zhang W, et al. miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma[J]. Am J Transl Res, 2016, 8(6):2609-2619.
[7] Shi W, Bruce J, Lee M, et al. MiR-449a promotes breast cancer progression by targeting CRIP2[J]. Oncotarget, 2016, 7(14):18906-18918.
[8] 花本林, 付欣鸽, 胡文浩, 等. 乳腺癌和癌旁乳腺组织中Notch1基因mRNA及蛋白的表达[J]. 中华病理学杂志, 2009, 38(12):806-809.
[9] Wang B, Yang Z, Wang H, et al. MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A[J]. Am J Cancer Res, 2015, 5(9):2719-2729.
[10] Pan Y, Jiao G, Wang C, et al. MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1[J]. Biomed Pharmacother, 2016, 83:1398-1406.
[11] Wang V, Wu W. MicroRNA-based therapeutics for cancer[J]. BioDrugs, 2009, 23(1):15-23.
[12] Xia W, Zhou J, Luo H, et al. MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7[J]. Cancer Cell Int, 2017, 17:14.
[13] Zhou L, Zhao LC, Jiang N, et al. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2[J]. Eur Rev Med Pharmacol Sci, 2017, 21(1):87-94.
[14] 张楹怡, 田卫平, 梅玫. miR-21与DNA甲基化在不同乳腺癌细胞中的相互作用[J]. 中国应用生理学杂志, 2015, 31(3):220-224.
[15] 杜立树, 平龙玉, 王莹莹. 肺癌细胞株中miRNA-449 a的表达与生物学机制探讨[J]. 临床和实验医学杂志, 2015(4):299-301.
[16] Sandbothe M, Buurman R, Reich N, et al. The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4[J]. J Hepatol, 2017, 66(5):1012-1021.
[17] Sun X, Liu S, Chen P, et al. miR-449a inhibits colorectal cancer progression by targeting SATB2[J]. Oncotarget, 2016, 66(5):1012-1021.
[18] 卢彦珍, 王佳, 宋娟, 等. NOTCH1信号通路介导白藜芦醇抗肝缺血/再灌注所致大鼠心脏损伤保护作用的机制研究[J]. 中国应用生理学杂志, 2016, 32(4):351-355.
[19] Axelson H. Notch signaling and cancer:emerging complexity[J]. Semin Cancer Biol, 2004, 14(5):317-319.
[20] Hsu KW, Fang WL, Huang KH, et al. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression[J]. Oncotarget, 2016, 7(25):38036-38051.
[21] 孙国栋, 郑名华, 田南南, 等. miRNA-191对人乳腺癌细胞增殖、侵袭的影响[J]. 广东药学院学报, 2015, 31(1):99-103.